Exactly stockman that's what I planned to answer PIH2000, the expenses are on our partner (or the entity shared with these partners).

On top of that, if I'm not wrong, I think that most of the proteins are not new, it is the equivalent of applying for generic drugs, the path to approval is much shorter..